President Trump just gave cannabis investors something they've been waiting for.Shares of Tilray Brands (TLRY +28.04%) soared today, finishing up 27.5%. The jump came as the S&P 500 lost 0.3% and the Nasdaq Composite gained 0.2%.The cannabis company's stock is rising after President Donald Trump confirmed that his administration is looking into reclassifying marijuana -- a move that could be a game changer for the cannabis industry.NASDAQ : TLRYTilray BrandsToday's Change( 28.04 %) $ 3.06Current Price$ 13.9 ...

Tilray’s jump in a broad cannabis rally shows how shifting U.S. policy signals are jolting traders, today, Dec. 16, 2025.NASDAQ : TLRYTilray BrandsToday's Change( 27.54 %) $ 3.01Current Price$ 13.94Key Data PointsMarket Cap$1.3BDay's Range$ 10.50 - $ 14.5552wk Range$ 3.51 - $ 23.20Volume47MAvg Vol9MGross Margin20.17 %Tilray Brands (TLRY +27.54%), global medical cannabis producer, closed Tuesday’s session at $13.94, up 27.54%. Trading volume reached 46.8 million shares, about 525% above its three-month avera ...

Tilray (TLRY) shares soared about 30% today after President Donald Trump said he’s “strongly” considering an executive order that will reclassify cannabis as a Schedule III drug. The expected mandate will also authorize a pilot program that will enable seniors to access cannabis products under Medicare coverage, according to media reports on Tuesday. More News from Barchart Following today’s surge, Tilray stock is up more than 100% versus its recent low set on Dec. 4. www.barchart.com What Cannabis R ...

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Tuesday.Shares of Cementos Pacasmayo SAA – ADR (NYSE:CPAC) rose sharply during Tuesday's session after Holcim signed an agreement to purchase 50.01% of the company’s owner, Inversiones Aspi. S.A. of the Hochschild Group.Cementos Pacasmayo shares jumped 47.4% to $10.30 on Tuesday.Here are some other big stocks recording gains in today’s session.Rezolve AI PLC (NASDAQ:RZLV) gained 23.7% to $2.87 after the company reported prelimi ...

Core Insights - Canadian cannabis stocks are gaining attention as sector sentiment improves, with significant exposure to the U.S. market through brands and partnerships [1] - The U.S. cannabis industry is expanding, with total sales exceeding $32 billion annually and projections to surpass $50 billion by 2030, keeping Canadian operators relevant [1] - Renewed discussions on federal cannabis reform and regulatory changes are creating momentum for Canadian cannabis stocks, which often react sharply to U.S. policy developments [1] Company Summaries Tilray Brands (TLRY) - Tilray is a diversified cannabis and consumer products company with operations in cultivation, processing, and branded product distribution, expanding into beverages and wellness products for revenue stability [3][6] - The company has exposure to the U.S. market through hemp-derived products and THC offerings, with strategic partnerships enhancing national distribution [6] - Financially, Tilray is navigating a challenging environment with modest year-over-year revenue growth, unprofitability, and improved adjusted margins across segments [7] Canopy Growth (CGC) - Canopy Growth is a prominent Canadian cannabis producer with a broad portfolio of adult-use and medical brands, including flower, vapes, edibles, and infused beverages [8][10] - The company maintains indirect exposure to the U.S. market through affiliated entities, allowing participation in the U.S. THC market without direct federal conflict [10] - Recent financial results show operational improvement with increased quarterly revenue and reduced operating expenses, although profitability has not yet been achieved [11] Aurora Cannabis (ACB) - Aurora Cannabis focuses primarily on medical cannabis, operating cultivation and distribution facilities across multiple countries, including Europe and Australia [12][14] - The company has limited direct U.S. cannabis exposure but trades on NASDAQ, providing access for U.S. investors [14] - Recent financial results indicate progress toward stabilization, with increased medical cannabis revenue and improved gross margins, while maintaining solid cash reserves [15]

The legal status of marijuana in the U.S. remains scattered and confusing.A sharp pull-back in marijuana stocks dinged the value of Tilray Brands (TLRY 10.04%) shares on Monday. At the end of last week, investor hopes rose that President Donald Trump would take an important step toward the de facto legalization of the drug, but those hopes didn't materialize on Monday. Investors eagerly sold out of Tilray, leaving the stock with a 10% loss that trading session. Awaiting a signaturePot stock bulls came out i ...

Key Takeaways Weed stocks dropped Monday afternoon, reversing early gains on hopes President Trump could soon issue an executive order reclassifying marijuana. An expected reclassification from a Schedule I to a Schedule III drug would help companies in the sector reduce their taxes and relax banking restrictions. Weed stocks aren't flying so high anymore. Shares of Tilray Brands (TLRY) dropped nearly 5%, Canopy Growth (CGC) slipped 3%, and other cannabis stocks also lost ground in recent trading, reve ...

Canadian cannabis stocks, including Tilray (TLRY), surged following reports that President Donald Trump could sign an executive order as soon as Monday reclassifying marijuana from a Schedule I drug like heroin to the less-restrictive Schedule III category, alongside steroids and codeine. The potential reclassification would allow cannabis companies to deduct business expenses under IRS rules, improve access to banking services, and enable expanded medical research. More News from Barchart Valued at a ...

Tilray Brands, Inc. (TLRY) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TLRY crossed above the 20-day moving average, suggesting a short-term bullish trend.The 20-day simple moving average is a popular investing tool. Traders like this SMA because it offers a look back at a stock's price over a shorter period and helps smooth out price fluctuations. The 20-day can also show more trend reversal signals than longer-term moving avera ...

Tilray Brands, Inc. (TLRY) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TLRY crossed above the 200-day moving average, suggesting a long-term bullish trend.The 200-day simple moving average is a useful tool for traders and analysts, establishing market trends for stocks, commodities, indexes, and other financial instruments over the long term. The marker moves higher or lower along with longer-term price moves, and serves as a sup ...